Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Vicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare Conference


Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will participate in the TD Cowen 44th Annual Healthcare Conference.

Management is scheduled to present on Tuesday, March 5, 2024 at 2:10 p.m. ET. A live webcast of the presentation will be accessible to the public on the "Investors" section of the Company's website at https://investor.vicarioussurgical.com. An archive of the webcast will be available for replay following the conference.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company's novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla's Khosla Ventures, Innovation Endeavors, Jerry Yang's AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang's E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com.


These press releases may also interest you

at 11:00
"I've experienced intermittent back pain for years. I tried bolstering my knees, but I change sleeping positions throughout the night," said an inventor, from Round Rock, Texas, "so I invented THE SPINE ALIGN FOR SLEEP. My design enables you to...

at 10:40
The food fortification market size is to be valued at US$ 106.7 billion by 2024. The market valuation is estimated to be US$ 286 billion by 2034, projected at a...

at 10:35
Probiotics in Animal Feed Market is Segmented by Type (Bacteria Source, Yeast Source), by Application (Cattle, Poultry, Swine, Aquaculture). The Global Probiotics in Animal Feed Market was valued at USD 3897.4 Million in 2023 and is anticipated to...

at 10:30
GenomOncology (GO) revealed today an upgraded version of GO Pathology Workbench, their software platform for tertiary analysis and reporting of next generation sequencing (NGS) and other molecular testing results. This version includes expanded...

at 10:30
Cancer Biomarkers Market in terms of revenue was estimated to be worth $24.5 billion in 2024 and is poised to reach $42.0 billion by 2029, growing at a CAGR of 11.3% from 2024 to 2029 according to a new report by MarketsandMarketstm. Increasing...

at 10:30
Future Market Insights (FMI) predicts a surge in the plant stem cell skincare product market. This growth is primarily driven by rising consumer demand for multi-benefit skincare solutions. Consumers are increasingly seeking products that offer...



News published on and distributed by: